ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $49,000 | -34.7% | 102,516 | -8.1% | 0.00% | – |
| Q4 2015 | $75,000 | -26.5% | 111,509 | +5.5% | 0.00% | – |
| Q3 2015 | $102,000 | -17.1% | 105,664 | +3.1% | 0.00% | – |
| Q2 2015 | $123,000 | +21.8% | 102,517 | +7.4% | 0.00% | – |
| Q1 2015 | $101,000 | -2.9% | 95,469 | -0.4% | 0.00% | – |
| Q4 2014 | $104,000 | 0.0% | 95,812 | +0.4% | 0.00% | – |
| Q3 2014 | $104,000 | -48.0% | 95,468 | -50.0% | 0.00% | – |
| Q2 2014 | $200,000 | -25.4% | 190,938 | -26.5% | 0.00% | – |
| Q1 2014 | $268,000 | -14.9% | 259,736 | -4.2% | 0.00% | – |
| Q4 2013 | $315,000 | -73.1% | 271,154 | -61.2% | 0.00% | – |
| Q3 2013 | $1,172,000 | +125.4% | 698,156 | +168.3% | 0.00% | – |
| Q2 2013 | $520,000 | – | 260,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ativo Capital Management LLC | 416,564 | $575,000 | 0.20% |
| ALGERT GLOBAL LLC | 124,891 | $150,000 | 0.08% |
| Rotella Capital Management, Inc. | 64,910 | $78,000 | 0.06% |
| Spark Investment Management LLC | 362,800 | $431,000 | 0.06% |
| Icahn Capital | 5,904,863 | $7,086,000 | 0.02% |
| GLOBEFLEX CAPITAL L P | 99,954 | $120,000 | 0.02% |
| Kovack Advisors, Inc. | 16,050 | $19,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 110,202 | $132,000 | 0.01% |
| Renaissance Technologies | 3,614,909 | $4,338,000 | 0.01% |
| CSS LLC/IL | 158,829 | $191,000 | 0.01% |